Usana Health Sciences INC Form 4 insider transactions

Joshua Foukas, Chief Legal Officer of USANA Health Sciences, reports the acquisition of restricted stock units.

CEO and President of USANA Health Sciences, Jim Brown, received 109,882 restricted stock units on February 27, 2025, according to a Form 4 filing with the SEC.

Director Peggie Pelosi reported selling 780 shares of USANA Health Sciences Inc. common stock on February 27, 2025.

Peter Benedict, Chief Information Officer of USANA Health Sciences Inc, reports transactions involving common stock and restricted stock units on February 8, 2025.

Chief Operating Officer Noot Walter reports transactions involving USANA Health Sciences stock, including the exercise of restricted stock units and subsequent disposal of shares to cover tax obligations.

Chief Commercial Officer of USANA Health Sciences, Brent Neidig, reports transactions involving common stock and restricted stock units.

Chief Sales Officer David Mulham reports transactions involving USANA Health Sciences stock, including the vesting of restricted stock units.

Paul A. Jones, Chief People Officer of USANA Health Sciences, reports transactions involving common stock and restricted stock units on February 8, 2025.

G. Doug Iieking, CFO of USANA Health Sciences, reports the acquisition and disposal of common stock and restricted stock units on February 8, 2025.

Kevin Guest, Executive Chairman of USANA Health Sciences, reports transactions involving common stock and restricted stock units on February 8, 2025.

Chief Legal Officer Joshua Foukas reports transactions involving USANA Health Sciences stock, including the exercise of restricted stock units and subsequent disposal of shares to cover tax obligations.

CEO Jim Brown reports transactions involving USANA Health Sciences stock, including the vesting and disposal of restricted stock units.

Peter Benedict, Chief Information Officer of USANA Health Sciences, reports the vesting and subsequent disposal of restricted stock units.

Chief Operating Officer Noot Walter reports the vesting and disposal of restricted stock units in USANA Health Sciences.

Chief Commercial Officer Brent Neidig reports transactions involving USANA Health Sciences Inc. stock, including the vesting and disposal of restricted stock units.

David Mulham, Chief Sales Officer of USANA Health Sciences Inc, reports the acquisition of common stock through the vesting of restricted stock units on February 6th and 7th, 2025.

Paul A. Jones, Chief People Officer of USANA Health Sciences, reports transactions involving common stock and restricted stock units.

Chief Financial Officer Doug Iiekkings of USANA Health Sciences Inc. reports transactions involving common stock and restricted stock units.

Kevin Guest, Executive Chairman of USANA Health Sciences, reports transactions involving common stock and restricted stock units.

Joshua Foukas, Chief Legal Officer of USANA Health Sciences, reports transactions involving restricted stock units and common stock.

CEO Jim Brown reports exercising stock options and selling shares of USANA Health Sciences in early February 2025.

Director Timothy E. Wood of USANA Health Sciences Inc. reported the acquisition of 674 common stock units and the disposal of 169 common stock units on February 2, 2025.

Frederic J Winssinger, a director at USANA Health Sciences, acquired 674 shares of common stock through the vesting of restricted stock units.

Director J. Scott Nixon acquired 674 shares of USANA Health Sciences common stock through the vesting of restricted stock units.

A director at USANA Health Sciences, Inc. recently exercised stock options, acquiring and subsequently disposing of shares, according to a recent SEC filing.

Director Gilbert A. Fuller acquired 674 shares of USANA Health Sciences common stock through the vesting of restricted stock units.

Director John Turman Fleming acquired 674 shares of USANA Health Sciences common stock through the vesting of restricted stock units.

Director Xia Ding of USANA Health Sciences Inc. reported the acquisition of 674 common stock units and the disposal of 169 common stock units on February 2, 2025.

Myron W. Wentz, a director and 10% owner of USANA Health Sciences, disposed of 123,000 shares of common stock through Gull Global Limited on November 13, 2024.

Director Timothy E. Wood reports the vesting and disposal of restricted stock units in USANA Health Sciences.